Tuvonralimab
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P99540-1MG | 1 mg | 456,00 | Add | |
| HY-P99540-5MG | 5 mg | 1'153,00 | Add | |
| HY-P99540-10MG | 10 mg | 1'851,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab[1].
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Immunology/Inflammation |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: Phase 1 |
| CAS-Number | 2417649-44-4 |
| Disclaimer | Shipped on dry ice - extra freight charge will occur |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Dry Ice |
| Material Safety Data Sheet | Download PDF |
